Massive Bio and Mika Health partner to combine AI and biomarker testing for cancer patients, increasing access to treatments and digital therapeutics.
Massive Bio and Mika Health have partnered to combine AI and next-generation sequencing biomarker testing, empowering cancer patients in treatment and those searching for clinical trials in the US and Europe. The collaboration aims to increase free access to Mika's Digital Therapeutic for treating oncology-related fatigue, anxiety, and depression, while also accelerating access to appropriate treatments.
June 02, 2024
3 Articles